Weedstock - Cannabis Market Intelligence | Stock Tracker & News

Real-time cannabis stock tracking, expert market analysis, and breaking marijuana industry news.

Cannabis Market Intelligence & Stock Tracker – Real-Time Analysis | Weedstock

⭐ Top Story

📈 Top Movers

📰 Today's News

🌿

From the Village Green

Daily curated intelligence from social media — cannabis market trends, breaking news, regulatory updates & M&A signals

# From the Village Green

Curated from social media posts and threads

## Aurora Cannabis Reports Record FY2026 Medical Revenue

Canadian medical cannabis leader Aurora (ACB) posted record annual global medical revenue of $288.6M (+18% YoY) and adjusted EBITDA of $53.8M (+32% YoY) in FY2026. Company acquired EU-GMP facility and exits lower-margin units to focus on premium medical cannabis.

[Read full article](https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2439329/aurora-cannabis-posts-record-fy2026-medical-revenue-buys-eu-gmp-facility-as-it-exits-lower-margin-units/)

## Trulieve Makes Historic NYSE Debut as First U.S. Cannabis Company on Major Exchange

Trulieve (TRUL) began trading on the New York Stock Exchange on June 10, becoming the first U.S. cannabis company listed on a major exchange. The milestone was enabled by federal cannabis rescheduling from Schedule I to Schedule III in April 2026. Trulieve operates 200+ retail locations across the U.S.

[Read full article](https://www.aol.com/articles/better-marijuana-stock-buy-now-100500000.html)

## Drug Testing Industry & Pharma Groups Challenge Cannabis Rescheduling in Federal Court

A drug testing industry coalition and cannabis-focused biopharmaceutical corporation filed with federal appeals court to block the Trump administration’s cannabis rescheduling, arguing marijuana is a “dangerous drug.” The challenge represents ongoing regulatory headwinds despite April 2026 rescheduling momentum.

[Read full article](https://www.marijuanamoment.net/drug-testing-industry-tries-to-block-cannabis-rescheduling-newsletter-june-12-2026/)

## Florida Regulators Consider Medical Cannabis Advertising & Marketing Rule Updates

Florida’s Division of Cannabis Regulation announced proposed changes to medical cannabis advertising and marketing rules, signaling regulatory evolution in the nation’s second-largest cannabis market. Updates expected to create clearer guidance for operators and brands navigating compliance.

## Colorado Cannabis Industry Faces Illegal Operation Crackdown

Colorado regulators warned of widespread illegal activity in the state’s cannabis industry. Mammoth Farms CEO Justin Trouard highlighted criminal operations undermining legal market integrity. Private industry meeting revealed scope of black market competition and enforcement challenges.

[Read full article](https://www.cbsnews.com/colorado/news/colorado-illegal-activity-marijuana-industry/)

## Nevada Cannabis Advisory Commission Schedules Subcommittee Meetings

Nevada’s Cannabis Advisory Commission subcommittees meet Tuesday to discuss regulatory matters. Agenda includes industry compliance updates, licensing initiatives, and market oversight. Nevada continues strengthening regulatory framework for growing local cannabis sector.

## Illinois Regulators Revise Cannabis Forms for New Accessibility Standards

Illinois cannabis regulators updated application and regulatory forms to meet new accessibility compliance standards. Changes include enhanced digital formats and ADA compliance features, streamlining licensing process for operators applying in the competitive Illinois market.

## New York Cannabis Market Elevated by California Cultivators & Regulatory Reform

California brand Alien Labs invested over a year upgrading New York indoor cultivation operations after regulators loosened restrictions. New York now features legitimate indoor grows from national talent, moving away from outdoor-only production model. Market quality and professionalism advancing rapidly.

[Read full article](https://hightimes.com/culture/high-times-strains-of-the-month-june-2026/)

## Australian Cannabis Investors Demand Clinical Evidence Over Market Speculation

ASX cannabis companies face investor pressure to demonstrate revenue generation and clinical proof-of-concept rather than relying on market hype. 2026 marks critical juncture where investors and regulators increasingly distinguish between proven revenue generators and speculative plays in ANZ cannabis sector.

[Read full article](https://cedclinic.com/asx-cannabis-stocks-2026-why-proof-matters-more-than-hype-kalkine-media/)

## Aurora Cannabis Signals Strong 2026, Navigates FY2027 Transition in Canada

Aurora management highlighted double-digit revenue growth, best-in-class margins, and rising international sales on FY2026 earnings call. FY2027 projected as transitional year as Canadian medical reimbursement cuts impact domestic revenue. International expansion critical to growth strategy.

[Read full article](https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2449899/aurora-cannabis-signals-strong-2026-transitional-2027/)

—

**The Village Green** is your daily cannabis industry intelligence brief. Curated by Sheeba from Twitter/X, Reddit, LinkedIn, and industry news sources. Last updated: Saturday, June 13, 2026 at 7:30 AM ET.

📅 Yesterday's News & Older Articles →